GO:0004493 methylmalonyl-CoA epimerase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004493 methylmalonyl-CoA epimerase activity catalyzes the interconversion of (R)-methylmalonyl-CoA and (S)-methylmalonyl-CoA, a stereochemical inversion essential for propionate metabolism.
• The enzyme is encoded by MCEE in humans; biallelic pathogenic variants cause methylmalonyl-CoA epimerase deficiency, a rare inborn error of metabolism that can mimic propionic acidemia.
• Methylmalonyl-CoA epimerase (MCE) is required for the canonical methylmalonyl-CoA mutase (MUT)-dependent pathway that converts methylmalonyl-CoA to succinyl-CoA, linking propionate catabolism to the TCA cycle.
• In bacteria, MCE activity is essential for the sbm operon-dependent production of propionic acid and for engineered polyketide biosynthesis, making it a target for metabolic engineering.
• Structural and mechanistic studies, including substrate enolate intermediate capture, have defined the active-site architecture and catalytic residues of MCE from Streptomyces coelicolor and other sources.
• Research on GO:0004493 benefits from CRISPR-based knockout, point-mutation, knock-in, and overexpression models to dissect gene function and disease mechanisms.
Description
Methylmalonyl-CoA epimerase activity (GO:0004493) is a molecular function that catalyzes the reversible stereochemical inversion of (R)-methylmalonyl-CoA to (S)-methylmalonyl-CoA. This epimerization is a critical step in the propionate catabolic pathway, because the downstream enzyme methylmalonyl-CoA mutase (MUT) accepts only the (S)-stereoisomer as substrate. Without epimerase activity, methylmalonyl-CoA accumulates and cannot be efficiently converted to succinyl-CoA, leading to metabolic dysfunction. The enzyme is conserved from bacteria to humans and is encoded by the MCEE gene in humans. In bacteria, methylmalonyl-CoA epimerase is also involved in the production of propionic acid and in the biosynthesis of complex polyketides, where it supplies the correct stereoisomer of methylmalonyl-CoA for incorporation into secondary metabolites. The dual role of this enzyme in primary and secondary metabolism makes it a subject of interest for both clinical genetics and metabolic engineering. Research into GO:0004493 has been accelerated by structural biology, enzymology, and CRISPR-based genetic models, which together provide a framework for understanding its catalytic mechanism and its contribution to human disease.
methylmalonyl-CoA epimerase activity At A Glance
| GO ID | GO:0004493 |
|---|---|
| GO term | methylmalonyl-CoA epimerase activity |
| Ontology | molecular_function |
| Synonym | 2-methyl-3-oxopropanoyl-CoA 2-epimerase activity; DL-methylmalonyl-CoA racemase activity; methylmalonyl-CoA 2-epimerase activity; methylmalonyl-CoA racemase activity; methylmalonyl coenzyme A racemase activity |
| Definition | Catalysis of the reaction: (R)-methylmalonyl-CoA = (S)-methylmalonyl-CoA. |
| Major function | Interconverts (R)- and (S)-methylmalonyl-CoA, supplying the (S)-isomer for methylmalonyl-CoA mutase in propionate metabolism and for polyketide biosynthesis. |
| Human gene | MCEE (methylmalonyl-CoA epimerase) |
| Associated disease | Methylmalonyl-CoA epimerase deficiency (OMIM 251120), which can present with elevated methylmalonic acid and mimic propionic acidemia. |
| EC number | 5.1.99.1 |
What Is GO:0004493?
According to the Gene Ontology, GO:0004493 methylmalonyl-CoA epimerase activity is defined as the catalysis of the reaction: (R)-methylmalonyl-CoA = (S)-methylmalonyl-CoA. In other words, it is an isomerase that interconverts the two stereoisomers of methylmalonyl-CoA by breaking and reforming a carbon-hydrogen bond at the alpha-carbon, without changing the molecular formula. This activity is also known by synonyms such as methylmalonyl-CoA racemase activity, DL-methylmalonyl-CoA racemase activity, and 2-methyl-3-oxopropanoyl-CoA 2-epimerase activity.
Why Is methylmalonyl-CoA epimerase activity Important in Cell Biology?
GO:0004493 is important because it controls a stereochemical checkpoint in propionate metabolism that is essential for normal mitochondrial energy homeostasis and for preventing the accumulation of toxic metabolites. In humans, loss of methylmalonyl-CoA epimerase activity causes a rare autosomal recessive disorder, methylmalonyl-CoA epimerase deficiency, which can present with metabolic acidosis, hyperammonemia, and neurological symptoms similar to propionic acidemia. In biotechnology, the same activity is required for the efficient production of propionic acid and complex polyketides in engineered bacterial strains, making it a target for metabolic pathway optimization. Thus, understanding GO:0004493 has direct implications for both clinical diagnostics and industrial microbiology.
• Enables the conversion of (R)-methylmalonyl-CoA to (S)-methylmalonyl-CoA, the substrate for methylmalonyl-CoA mutase in propionate catabolism.
• Deficiency in humans causes methylmalonyl-CoA epimerase deficiency, a rare inborn error of metabolism that can mimic propionic acidemia.
• Mutations in MCEE are associated with elevated methylmalonic acid and clinical presentations including metabolic acidosis and neurological impairment.
• Required for the sbm operon-dependent production of propionic acid in Escherichia coli, relevant for industrial fermentation.
• Facilitates the supply of methylmalonyl-CoA extender units for complex polyketide biosynthesis in engineered bacteria.
• Provides a model system for studying enzyme stereochemistry and enolate intermediate stabilization.
• Serves as a potential target for metabolic engineering of pathways that require stereospecific methylmalonyl-CoA.
• Its activity can be measured by HPLC-based assays, enabling functional validation of genetic variants.
• CRISPR-based models of MCEE can help dissect its role in mitochondrial metabolism and disease.
• Conservation across species allows comparative studies of enzyme structure and function.
Molecular Mechanism of methylmalonyl-CoA epimerase activity
Substrate binding and stereochemical inversion
In simple terms: The enzyme grabs methylmalonyl-CoA and flips one of its chemical groups to change its shape.
Methylmalonyl-CoA epimerase binds (R)-methylmalonyl-CoA and catalyzes the reversible inversion of the alpha-carbon stereocenter to produce (S)-methylmalonyl-CoA. This step is essential because the downstream enzyme methylmalonyl-CoA mutase is stereospecific for the (S)-isomer. The reaction proceeds without a cofactor and involves a conserved active-site architecture that positions the substrate for proton abstraction and re-addition.
Enolate intermediate and catalytic residues
In simple terms: A temporary intermediate forms during the flip, and specific amino acids in the enzyme stabilize it.
Structural and mechanistic studies have captured a substrate enolate intermediate and a mimic in the active site of Streptomyces coelicolor methylmalonyl-CoA epimerase, revealing key catalytic residues that stabilize the enolate. This intermediate is characteristic of epimerases that operate via a deprotonation-reprotonation mechanism. The identification of these residues provides a template for understanding pathogenic variants in human MCEE.
Role in propionate metabolism
In simple terms: This enzyme is a necessary step in breaking down certain fatty acids and amino acids.
In humans, methylmalonyl-CoA epimerase functions in the mitochondrial propionate catabolic pathway, converting (R)-methylmalonyl-CoA to (S)-methylmalonyl-CoA for subsequent conversion to succinyl-CoA by methylmalonyl-CoA mutase. Defects in this pathway lead to methylmalonic acidemia, a group of disorders characterized by accumulation of methylmalonic acid. Isolated methylmalonyl-CoA epimerase deficiency is a rare cause of methylmalonic acidemia that can be overlooked because it mimics propionic acidemia.
Bacterial and biotechnological roles
In simple terms: Bacteria use this enzyme to make useful chemicals and antibiotics.
In bacteria, methylmalonyl-CoA epimerase is required for the sbm operon-dependent production of propionic acid in Escherichia coli, and its activity is essential for efficient flux through the pathway. It also supplies methylmalonyl-CoA for polyketide biosynthesis, as demonstrated by metabolic engineering of a methylmalonyl-CoA mutase-epimerase pathway for complex polyketide production in E. coli. These roles make the enzyme a target for optimizing industrial strains.
Enzyme assays and detection
In simple terms: Scientists can measure how fast this enzyme works using a chemical test.
An HPLC-based assay has been developed to measure methylmalonyl-CoA epimerase activity, enabling kinetic characterization and functional validation of variants. Such assays are important for confirming the impact of MCEE mutations identified in patients.
Key Genes Involved in GO:0004493 methylmalonyl-CoA epimerase activity
The following genes and proteins are directly or indirectly involved in methylmalonyl-CoA epimerase activity (GO:0004493) and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MCEE | Encodes methylmalonyl-CoA epimerase, the enzyme responsible for GO:0004493 | Pathogenic variants cause methylmalonyl-CoA epimerase deficiency; target for functional studies |
| MUT | Encodes methylmalonyl-CoA mutase, which converts (S)-methylmalonyl-CoA to succinyl-CoA | Downstream of MCEE; mutations cause methylmalonic acidemia |
| MMAA | Encodes a GTPase involved in maintaining methylmalonyl-CoA mutase activity | Associated with methylmalonic acidemia; may modify pathway flux |
| MMAB | Encodes a protein involved in adenosylcobalamin synthesis for methylmalonyl-CoA mutase | Related to methylmalonic acidemia; potential modifier of epimerase pathway |
| MMADHC | Involved in cobalamin metabolism affecting methylmalonyl-CoA mutase | Related to methylmalonic acidemia |
| PCCA | Encodes propionyl-CoA carboxylase alpha subunit, upstream of methylmalonyl-CoA | Defects cause propionic acidemia, which can mimic epimerase deficiency |
| PCCB | Encodes propionyl-CoA carboxylase beta subunit | Defects cause propionic acidemia |
| Sbm | Bacterial gene cluster for propionate utilization, requires epimerase activity | Model for propionic acid production in E. coli |
| YgfG | Bacterial methylmalonyl-CoA epimerase in E. coli | Studied for metabolic engineering of propionate pathway |
| YgfH | Bacterial propionyl-CoA:succinate CoA transferase in sbm operon | Part of the sbm operon with epimerase |
| Mce | Methylmalonyl-CoA epimerase in Streptomyces coelicolor | Structural and mechanistic studies of enolate intermediate |
| Mcm | Methylmalonyl-CoA mutase in bacteria | Partner enzyme for epimerase in polyketide biosynthesis |
| PKS | Polyketide synthase genes | Require methylmalonyl-CoA extender units supplied by epimerase |
| BDNF | Brain-derived neurotrophic factor, involved in mitochondrial quality control | Potential indirect link to mitochondrial metabolism; not directly related to GO:0004493 |
| SUCLG1 | Succinyl-CoA ligase subunit alpha | Downstream of succinyl-CoA in TCA cycle; potential context |
| SUCLA2 | Succinyl-CoA ligase subunit beta | Downstream of succinyl-CoA; potential context |
| ACAT1 | Acetyl-CoA acetyltransferase 1 | Involved in ketone body metabolism; not directly linked to GO:0004493 |
| HMGCL | 3-hydroxy-3-methylglutaryl-CoA lyase | Related to organic acidemias; not directly linked to GO:0004493 |
How Is methylmalonyl-CoA epimerase activity Regulated?
The regulation of methylmalonyl-CoA epimerase activity is not fully understood at the transcriptional level, but its function is tightly linked to the availability of its substrate and the activity of upstream and downstream enzymes in propionate metabolism. In humans, MCEE expression may be influenced by mitochondrial energy status and metabolic demand, but specific transcriptional regulators have not been definitively characterized in the cited literature. In bacteria, the sbm operon, which includes a methylmalonyl-CoA epimerase, is induced by propionate and regulated by global metabolic regulators, though detailed mechanisms remain to be fully elucidated. Post-translational modifications of MCEE have not been extensively reported in the cited studies.
methylmalonyl-CoA epimerase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MCEE | Methylmalonyl-CoA epimerase deficiency; elevated methylmalonic acid; metabolic acidosis | MCEE knockout or point-mutation cell lines (e.g., HEK293, HepG2) |
| MUT | Methylmalonic acidemia due to mutase deficiency | MUT knockout models; patient-derived fibroblasts |
| PCCA | Propionic acidemia | PCCA knockout cell lines; iPSC-derived hepatocytes |
| PCCB | Propionic acidemia | PCCB knockout models |
| Sbm operon | Propionic acid production in E. coli | Engineered E. coli strains with epimerase knockouts or overexpression |
Methylmalonyl-CoA epimerase deficiency
Biallelic pathogenic variants in MCEE cause methylmalonyl-CoA epimerase deficiency, a rare autosomal recessive inborn error of metabolism. Patients may present with metabolic acidosis, hyperammonemia, lethargy, and neurological symptoms, often mimicking propionic acidemia. Biochemical findings include elevated methylmalonic acid and methylcitric acid, but without the typical elevation of propionylcarnitine seen in propionic acidemia. Genetic and structural analyses of pathogenic variations have provided insights into the molecular basis of the disease.
Methylmalonic acidemia and related disorders
Isolated methylmalonic acidemia can result from defects in methylmalonyl-CoA mutase or its cofactor metabolism, and epimerase deficiency represents a rare subtype. The accumulation of methylmalonic acid is toxic to multiple organs, particularly the brain and kidneys. Understanding the role of GO:0004493 in this pathway is essential for differential diagnosis and for developing targeted therapies.
Biotechnological and metabolic engineering implications
In industrial microbiology, methylmalonyl-CoA epimerase activity is required for efficient production of propionic acid and complex polyketides in engineered bacteria. Deficiencies or imbalances in this activity can lead to reduced yields of desired products. Therefore, optimizing epimerase expression is a strategy for improving bioprocesses.
From methylmalonyl-CoA epimerase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of MCEE loss on mitochondrial metabolism? | MCEE knockout cell lines (e.g., HEK293, HepG2) generated by CRISPR |
| Do patient-specific MCEE variants impair enzyme activity? | Point-mutation knock-in cell lines expressing mutant MCEE |
| Can wild-type MCEE rescue the metabolic phenotype? | Knock-in or overexpression of wild-type MCEE in patient-derived cells |
| How does MCEE interact with downstream enzymes? | Tagged knock-in of MCEE (e.g., FLAG, GFP) for co-immunoprecipitation |
| What is the role of MCEE in propionate flux? | Overexpression of MCEE in E. coli or mammalian cells followed by metabolic flux analysis |
| Can we model epimerase deficiency in vitro? | CRISPR-engineered iPSCs differentiated into hepatocytes or neurons |
How to Study the methylmalonyl-CoA epimerase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC assay | Epimerase activity by separating (R)- and (S)-methylmalonyl-CoA | Functional validation of MCEE variants |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complexes | Mechanistic studies of catalytic residues |
| Site-directed mutagenesis | Effect of specific amino acid changes on activity | Identification of key catalytic residues |
| CRISPR knockout | Loss-of-function phenotype | Studying metabolic consequences of MCEE deficiency |
| CRISPR knock-in | Expression of mutant or tagged protein | Modeling patient variants or protein interactions |
| Metabolomics | Levels of methylmalonic acid and related metabolites | Diagnosis and pathway flux analysis |
| Stable isotope tracing | Flux through propionate pathway | Quantifying metabolic rewiring |
| Co-immunoprecipitation | Protein-protein interactions | Identifying MCEE binding partners |
Enzymatic activity assays
HPLC-based assays can directly measure methylmalonyl-CoA epimerase activity by separating and quantifying (R)- and (S)-methylmalonyl-CoA. These assays are essential for validating the functional impact of MCEE variants identified in patients.
Structural biology and mechanistic studies
X-ray crystallography and site-directed mutagenesis have been used to capture the substrate enolate intermediate and identify catalytic residues in Streptomyces coelicolor methylmalonyl-CoA epimerase. These approaches provide a framework for understanding human MCEE variants.
Genetic and genomic approaches
CRISPR-Cas9 knockout, point-mutation knock-in, and overexpression models enable the study of MCEE function in relevant cell types. Genomic sequencing of patient cohorts can identify novel MCEE variants, which can then be functionally characterized.
Metabolic flux analysis
Stable isotope tracing and metabolomics can quantify flux through the propionate pathway and assess the contribution of methylmalonyl-CoA epimerase activity. Such methods are valuable in both clinical research and metabolic engineering.
How CRISPR Can Be Used to Study GO:0004493 methylmalonyl-CoA epimerase activity
Knockout
CRISPR-Cas9 knockout of MCEE in human cell lines (e.g., HEK293, HepG2) can model methylmalonyl-CoA epimerase deficiency and reveal metabolic consequences such as methylmalonic acid accumulation. These models are useful for testing rescue strategies and for understanding disease mechanisms.
Point Mutation
Introducing patient-specific point mutations into the endogenous MCEE locus via CRISPR homology-directed repair allows functional assessment of variants in a native context. This approach can distinguish pathogenic from benign variants and provide insights into structure-function relationships.
Knock-in
Knock-in of tagged MCEE (e.g., FLAG or GFP) enables studies of protein localization, interactions, and stability. Knock-in of wild-type MCEE can also rescue phenotypes in knockout cells, confirming causality.
Overexpression
CRISPR activation or lentiviral overexpression of MCEE can increase epimerase activity, which is useful for metabolic engineering and for studying the effects of enhanced flux through the propionate pathway. Overexpression in bacterial systems can improve production of propionic acid or polyketides.
How EDITGENE Supports methylmalonyl-CoA epimerase activity Research
Researchers studying methylmalonyl-CoA epimerase activity-related genes often need to determine whether a candidate gene is causally involved in a metabolic or disease phenotype. This requires precise genetic models that can knockout, mutate, or overexpress the gene of interest in relevant cell types. EDITGENE provides a suite of CRISPR-based services to accelerate such studies, from single-gene editing to high-throughput library screening.
Contact EDITGENE today to design your custom CRISPR model for methylmalonyl-CoA epimerase activity research.
Frequently Asked Questions About methylmalonyl-CoA epimerase activity
What is methylmalonyl-CoA epimerase activity?
Methylmalonyl-CoA epimerase activity (GO:0004493) is the catalysis of the interconversion of (R)-methylmalonyl-CoA and (S)-methylmalonyl-CoA, a stereochemical inversion required for propionate metabolism.
What gene encodes methylmalonyl-CoA epimerase in humans?
The human gene encoding methylmalonyl-CoA epimerase is MCEE.
What diseases are associated with methylmalonyl-CoA epimerase deficiency?
Methylmalonyl-CoA epimerase deficiency is a rare inborn error of metabolism that can present with metabolic acidosis, hyperammonemia, and neurological symptoms, often mimicking propionic acidemia.
How is methylmalonyl-CoA epimerase activity measured?
It can be measured using an HPLC-based assay that separates and quantifies the (R)- and (S)-stereoisomers of methylmalonyl-CoA.
What is the role of methylmalonyl-CoA epimerase in bacteria?
In bacteria, it is required for propionate utilization and for supplying methylmalonyl-CoA for polyketide biosynthesis, making it important for metabolic engineering.
What are the synonyms for methylmalonyl-CoA epimerase activity?
Synonyms include methylmalonyl-CoA racemase activity, DL-methylmalonyl-CoA racemase activity, and 2-methyl-3-oxopropanoyl-CoA 2-epimerase activity.
Which pathway is methylmalonyl-CoA epimerase involved in?
It is involved in the propionate catabolic pathway, which converts propionyl-CoA to succinyl-CoA.
What is the catalytic mechanism of methylmalonyl-CoA epimerase?
The enzyme catalyzes a deprotonation-reprotonation reaction via an enolate intermediate, as shown by structural studies.
Can CRISPR be used to study methylmalonyl-CoA epimerase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to study MCEE function and disease mechanisms.
What model systems are used to study methylmalonyl-CoA epimerase deficiency?
Human cell lines (e.g., HEK293, HepG2), patient-derived fibroblasts, and iPSC-derived hepatocytes are commonly used, along with bacterial models for metabolic engineering.
Conclusion
Methylmalonyl-CoA epimerase activity (GO:0004493) is a fundamental enzymatic function that ensures the correct stereochemistry of methylmalonyl-CoA for both primary metabolism and secondary metabolite production. Its role in human health is underscored by methylmalonyl-CoA epimerase deficiency, a rare but clinically significant disorder that can mimic propionic acidemia. In biotechnology, the enzyme is essential for efficient propionate and polyketide production. Advances in structural biology and CRISPR-based genetic models continue to illuminate its mechanism and regulation, offering opportunities for therapeutic and industrial applications.
References
- 1. Adam MP et al.. 1993. Isolated Methylmalonic Acidemia.. PMID: 20301409
- 3. Abily-Donval L et al.. 2017. Methylmalonyl-CoA Epimerase Deficiency Mimicking Propionic Aciduria.. Int J Mol Sci 18(11) PMID: 29104221
- 4. Heuberger K et al.. 2019. Genetic, structural, and functional analysis of pathogenic variations causing methylmalonyl-CoA epimerase deficiency.. Biochim Biophys Acta Mol Basis Dis 1865(6):1265-1272 PMID: 30682498
- 5. Bobik TA et al.. 2003. HPLC assay for methylmalonyl-CoA epimerase.. Anal Bioanal Chem 375(3):344-9 PMID: 12589497
- 6. Dayem LC et al.. 2002. Metabolic engineering of a methylmalonyl-CoA mutase-epimerase pathway for complex polyketide biosynthesis in Escherichia coli.. Biochemistry 41(16):5193-201 PMID: 11955068
- 7. Stunkard LM et al.. 2022. Substrate Enolate Intermediate and Mimic Captured in the Active Site of Streptomyces coelicolor Methylmalonyl-CoA Epimerase.. Chembiochem 23(2):e202100487 PMID: 34856049
- 8. Gonzalez-Garcia RA et al.. 2017. Awakening sleeping beauty: production of propionic acid in Escherichia coli through the sbm operon requires the activity of a methylmalonyl-CoA epimerase.. Microb Cell Fact 16(1):121 PMID: 28716098
